CDT Environmental Technology Investment Holdings Ltd. — Form 20-F Summary
Reporting period: Fiscal year ended December 31, 2023. The filing is an annual Form 20-F, not a standalone fourth-quarter report. Financial statements are prepared under U.S. GAAP and presented in U.S. dollars; operating activities are concentrated in China and primarily denominated in RMB.
Business Context
CDT is a Cayman Islands holding company whose operating subsidiaries in China design, sell, install and maintain sewage treatment systems and provide sewage treatment services. Its principal business lines are rural sewage treatment systems and septic-tank treatment services. The company reported one operating segment and had 114 employees at year-end 2023.
Key Financial Metrics
| Metric | 2023 | 2022 | Change |
|---|---|---|---|
| Revenue | $34.21 million | $28.85 million | +18.6% |
| Gross profit | $11.38 million | $10.25 million | +11.0% |
| Gross margin | 33.3% | 35.5% | Down 2.3 percentage points |
| Income from operations | $8.61 million | $6.35 million | +35.5% |
| Net income | $7.02 million | $5.24 million | +34.0% |
| Net income attributable to CDT shareholders | $7.42 million | $5.78 million | +28.3% |
| Basic and diluted EPS | $0.81 | $0.63 | +28.6% |
| Operating cash flow | $(3.13) million | $(4.47) million | Improved, but remained negative |
| Cash and cash equivalents | $0.27 million | $0.20 million | +34.1% |
- Sewage treatment systems generated $32.27 million of revenue, up 21.5%; sewage treatment services generated $1.94 million, down 15.4%.
- Cost of revenue increased 22.7% to $22.83 million, exceeding revenue growth because of higher labor and material costs.
- Operating expenses declined 28.9% to $2.77 million, helped by lower audit, general and administrative, selling and credit-loss expenses.
- The company recorded a $0.09 million recovery from credit losses in 2023 versus a $0.47 million provision in 2022.
- Effective income tax rates were approximately 19.2% based on the income-statement discussion and 17.0% in the tax-rate reconciliation; the filing contains this presentation inconsistency.
- Total assets were $72.79 million and shareholders’ equity was $32.09 million at December 31, 2023.
Liquidity, Debt and Working Capital
- Working capital was approximately $24.2 million, based on current assets of $64.7 million and current liabilities of $40.5 million.
- Cash was only $0.27 million, while net accounts receivable were $29.08 million and current contract assets were $34.28 million.
- Days sales outstanding increased to 262 days from 220 days in 2022. Management expects future DSO to remain approximately 300 to 365 days because of lengthy government inspection and payment-approval procedures.
- Operating cash flow remained negative because of increases of approximately $9.24 million in accounts receivable and $13.58 million in contract assets, partly offset by a $9.22 million increase in accounts payable.
- Total contractual obligations were $8.73 million, including $2.73 million of short-term bank loans, $0.31 million of third-party loans, $5.39 million of related-party loans and $0.22 million of operating lease obligations. Approximately $8.55 million was due within one year.
- At year-end, bank debt totaled approximately $2.81 million, third-party loans totaled $0.31 million and related-party loans totaled $5.39 million. Many related-party loans were interest-free and payable on demand or had maturities in 2024.
- Management stated that existing working capital and expected collections should support operations for at least the next 12 months, but acknowledged reliance on collections, bank financing and shareholder or related-party support.
Cash Flow and Financing
| Cash flow item | 2023 | 2022 |
|---|---|---|
| Operating activities | $(3.13) million | $(4.47) million |
| Investing activities | $0.24 million | $(0.09) million |
| Financing activities | $2.99 million | $3.73 million |
| Net change in cash | $0.07 million | $(0.94) million |
Financing cash inflows primarily reflected bank borrowings and related-party loans. Capital expenditures were limited to approximately $22,000, principally for septic-tank treatment operations.
Material Changes Versus Prior Period
- Revenue growth accelerated through sewage treatment system installations, including four new projects with aggregate contract prices of approximately $35.4 million and completion of six projects during 2023.
- Gross margin contracted from 35.5% to 33.3% as labor and material costs grew faster than systems revenue.
- Operating profit and net income increased substantially because of revenue growth, lower operating expenses and recovery of previously reserved receivables.
- Receivables and contract assets expanded materially, resulting in continued negative operating cash flow despite reported profitability.
- Customer concentration shifted: two customers represented 23.4% and 10.2% of 2023 revenue, compared with three customers representing 48.5%, 15.2% and 14.6% in 2022.
- The company completed its initial public offering on April 22, 2024, after the reporting period, issuing 1.5 million shares at $4.00 per share and receiving approximately $4.3 million of net proceeds, including $0.6 million placed in escrow for 24 months.
- The ordinary shares began trading on Nasdaq under the symbol CDTG on April 18, 2024. Shares outstanding increased from 9.2 million at December 31, 2023 to 10.7 million as of May 9, 2024.
- The company changed its independent registered public accounting firm in April 2024 from Wei, Wei & Co., LLP to Enrome LLP. The filing reports no disagreements or reportable events related to the change.
Guidance, Outlook and Unusual Items
- Management expects revenue from sewage treatment systems to continue growing during 2024 and beyond, supported by project execution and recovery following the lifting of China’s COVID-19 restrictions.
- As of April 30, 2024, reported backlog consisted of the Lianjiang Project and Wuyishan Project—Phase 2, with tentative aggregate contract value of approximately RMB170 million, or $23.2 million.
- The Lianjiang Project, contracted at approximately RMB140 million, was expected to be completed by July 2024. Wuyishan Phase 2, contracted at approximately RMB30 million, was expected to be completed by May 2024.
- The company was pursuing three additional projects expected to be signed and commenced by the third quarter of 2024, but stated that acquisition and completion were not guaranteed.
- The company has no formal earnings guidance in the filing and does not expect to pay cash dividends in the foreseeable future.
- The company identified two material weaknesses in internal control over financial reporting: insufficient U.S. GAAP and SEC-reporting expertise and the absence of a formal internal audit and risk-assessment framework. Management stated that these weaknesses had not been fully remediated at December 31, 2023.
- As of the filing date, the company reported no material legal proceedings or material cybersecurity incidents. It also reported no material off-balance-sheet arrangements.
- Potential contingencies include liquidated damages under the Zhongshan Project, possible penalties or arrears for unpaid social insurance and housing provident fund contributions, and risks associated with unbilled contract assets and delayed government inspections.
Principal Investor Verification Points
- Verify collection performance of the $29.1 million of net receivables and $39.2 million of total contract assets, particularly the balances aged beyond 360 days.
- Assess whether negative operating cash flow and $8.55 million of obligations due within one year are adequately covered by collections, IPO proceeds and refinancing capacity.
- Reconcile the filing’s inconsistent effective tax-rate disclosures and confirm the continuing availability of preferential PRC tax treatments.
- Review the accuracy of project completion estimates, cost-to-complete assumptions and revenue recognized under the cost-to-cost method.
- Monitor gross-margin pressure from labor and material costs and dependence on a limited vendor base, including one vendor representing 27.3% of 2023 purchases.
- Evaluate customer concentration, government payment approvals and the financial effect of delays or disputes on major projects.
- Track remediation of the two material weaknesses and the company’s ability to meet Nasdaq and SEC reporting requirements.
- Review related-party financing, including $5.39 million of related-party loans and guarantees provided by the chief executive officer or other affiliates.
- Confirm completion, billing and cash conversion of the Lianjiang, Wuyishan Phase 2 and Zhongshan projects, including any potential liquidated damages.
- Consider China regulatory, foreign-exchange, dividend-repatriation, PCAOB inspection, currency and Cayman Islands shareholder-enforcement risks.